S&P ASX All Technology

US Dollar vs AUD

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

MTNB Matinas Biopharma Holdings Inc

0.5697

-0.0063 (-1.09%)

Last Updated: 04:18:51

Delayed by 15 minutes

Form 3 - Initial statement of beneficial ownership of securities

Matinas Biopharma (AMEX:MTNB)
Historical Stock Chart
From Jan 2025 to Feb 2025

Click Here for more Matinas Biopharma Charts.

Matinas Biopharma (AMEX:MTNB)
Historical Stock Chart
From Feb 2024 to Feb 2025

Click Here for more Matinas Biopharma Charts.

Matinas Biopharma Holdings Inc News

Form 3 - Initial statement of beneficial ownership of securities
Wednesday 26 February 2025 (2 days ago) • Edgar (US Regulatory)

Form PRE 14A - Other preliminary proxy statements
Saturday 22 February 2025 (6 days ago) • Edgar (US Regulatory)

Form SCHEDULE 13D - General Statement of Acquisition of Beneficial Ownership
Saturday 22 February 2025 (6 days ago) • Edgar (US Regulatory)

Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
Thursday 20 February 2025 (1 week ago) • Edgar (US Regulatory)

Form 8-K - Current report
Friday 14 February 2025 (2 weeks ago) • Edgar (US Regulatory)

Matinas BioPharma Announces Agreement for the Acquisition of Preferred Stock and Appointment of Dr. Robin L. Smith to the Board of Directors
Friday 14 February 2025 (2 weeks ago) • GlobeNewswire Inc.

Form 8-K - Current report
Wednesday 12 February 2025 (2 weeks ago) • Edgar (US Regulatory)

Form 8-K - Current report
Friday 7 February 2025 (3 weeks ago) • Edgar (US Regulatory)

Matinas BioPharma Appoints Evelyn D’An to Board of Directors as Audit Committee Chair
Friday 7 February 2025 (3 weeks ago) • GlobeNewswire Inc.

Form 8-K - Current report
Saturday 25 January 2025 (1 month ago) • Edgar (US Regulatory)

Form 8-K - Current report
Saturday 11 January 2025 (2 months ago) • Edgar (US Regulatory)

Matinas BioPharma Receives NYSE Noncompliance Notice
Saturday 11 January 2025 (2 months ago) • GlobeNewswire Inc.

More Matinas Biopharma Holdings Inc News Articles

Societe Generale Effekten

Societe Generale Effekten

Vontobel Financial Produ...

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions